You are currently viewing the summary.
View Full TextLog in to view the full text
AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions.
More options
Download and print this article for your personal scholarly, research, and educational use.
Buy a single issue of Science for just $15 USD.
Summary
A flurry of reports this year on new genes for Mendelian disorders—rare diseases caused by a defect in a single gene—takes advantage of cheap, next-generation DNA-sequencing technologies that make it possible, for a few thousand dollars, to sequence the 1% of the genome that codes for proteins, known as exons. This so-called exome sequencing has reinvigorated the field.
